Home » Medtronic Joins With Alnylam to Treat Huntington’s Disease
Medtronic Joins With Alnylam to Treat Huntington’s Disease
Medtronic said it will form an alliance with a pharmaceutical firm and research foundation to develop a unique drug/device therapy to treat Huntington’s disease.
MedCity News
MedCity News
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May